USPTO 2015–2025 USPTO PatentsView US Corporation

St. Jude Medical, Llc

USPTO PatentsView assignee record - 131 granted patents across 15 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

131

Total patents granted

CPC technology areas

17.1

Avg claims per patent

-68%

5-year filing velocity

The verdict

St. holds 131 US patents across 15 technology areas, rank #2,920 of 50,000 tracked assignees.

#2,920
of 50,000 US assignees by volume: Top 24%
by Innovation Score (45.2/100): 17.1
avg claims per patent: -68%
filing velocity, last 5 yrs

Portfolio overview

St. Jude Medical, Llc has been granted 131 US utility patents between 2015 and 2025, placing St. Jude Medical, Llc at rank #2,920 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.1 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, St. Jude Medical, Llc is one of the more focused assignees in the PatentsView dataset. By volume, St. sits between Shenzhen Qianhai Patuoxun Network AND Technology Co., Ltd. (131 patents, rank #2,916) and Xiamen University (131 patents, rank #2,924) - the closest US assignees by grant volume. The composite Innovation Score of 45.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 32 grants, compared with 99 in the 2015–2019 window, a -68% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. St. Jude Medical, Llc's 17.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark St. Jude Medical, Llc against peers pursuing similar technology classes.

Shenzhen Qianhai…

131
SHPP Global B V

131
Sanford

131
St Jude Children'…

131
THE CODE

131
The Raymond

131
VKR Holding A/S

131
Xiamen University

131
St Jude Medical ◀

131

What this shows St. holds 131 patents at rank #2,920, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near St

By rank, the assignees closest to #2,920 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in St's primary technology class.

St.'s Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

St. Jude Medical, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	17	13.0%
2016	24	18.3%
2017	26	19.8%
2018	14	10.7%
2019	18	13.7%
2020	6	4.6%
2021	5	3.8%
2022	10	7.6%
2023	3	2.3%
2024	6	4.6%
2025	2	1.5%

Which technologies does St. Jude Medical, Llc patent most?

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 101

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 47

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 8

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 6

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 6

B25G - HANDLES FOR HAND IMPLEMENTS 5

B25B - TOOLS OR BENCH DEVICES NOT OTHERWISE PROVIDED FOR, FOR FASTENING, CONNECTING, DISENGAGING OR HOLDING 5

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2

B29L - INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES 2

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 2

B29K - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR ; MOULDS, ; REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS 2

A61C - DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE 1

G01B - MEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS 1

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 1

Top 15 of 15 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#2,920

Across all tracked assignees

Innovation Score

45.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does St. Jude Medical, Llc hold?

St. Jude Medical, Llc holds 131 US granted patents filed between 2015 and 2025, spanning 15 technology areas.

What is St. Jude Medical, Llc's Innovation Score?

St. Jude Medical, Llc has an Innovation Score of 45.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does St. Jude Medical, Llc focus on?

St. Jude Medical, Llc's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 101 patents. The company has filed patents in 15 CPC subclasses total.

Is St. Jude Medical, Llc's patent filing rate increasing or decreasing?

St. Jude Medical, Llc's recent filing velocity is -68% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for St. Jude Medical, Llc's patents?

St. Jude Medical, Llc's patents average 17.1 claims each. This falls within the standard range, providing solid legal coverage.

How is the St. Jude Medical, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

St.'s 131 grants land it in the top 24% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - St. ranks #2,920 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.